Triglyceride Treatment in the Age of Cholesterol Reduction.

about

Increased midlife triglycerides predict brain β-amyloid and tau pathology 20 years later.

P2860

Q47288599-611FBD19-3CB9-4FF2-9ECC-D7BB6C4E0D12

P2860

Triglyceride Treatment in the Age of Cholesterol Reduction.

Item

http://www.wikidata.org/entity/Q38932760

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Triglyceride Treatment in the Age of Cholesterol Reduction.

@en

type

Item

label

Triglyceride Treatment in the Age of Cholesterol Reduction.

@en

prefLabel

Triglyceride Treatment in the Age of Cholesterol Reduction.

@en

P1476

Triglyceride Treatment in the Age of Cholesterol Reduction.

@en

P2093

Ira J Goldberg

http://www.w3.org/2001/XMLSchema#string

Namrata Gumaste

http://www.w3.org/2001/XMLSchema#string

Nidhi Agrawal

http://www.w3.org/2001/XMLSchema#string

Patricia Freitas Corradi

http://www.w3.org/2001/XMLSchema#string

P2860

Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline

Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23

Effect of estrogen on post-heparin lipolytic activity. Selective decline in hepatic triglyceride lipase

Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Loss-of-function mutations in APOC3, triglycerides, and coronary disease

Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Québec Cardiovascular Study.

Treatment options for hypertriglyceridemia: from risk reduction to pancreatitis.

The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspects.

P304

107-118

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.PCAD.2016.08.003

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27544319

http://www.w3.org/2001/XMLSchema#string

P921

triglyceride

P932

5364728

http://www.w3.org/2001/XMLSchema#string

Triglyceride Treatment in the Age of Cholesterol Reduction.

about

P2860

P2860

Triglyceride Treatment in the Age of Cholesterol Reduction.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932